Albumin: a look at the evidence.
Basta
S A
SA
Department of Internal Medicine/Infectious Diseases, Eastern Virginia School of Medicine, Norfolk, USA.
Oldfield
E C
EC
D001424:Bacterial Infections / Q000188:drug therapy*; D002439:Cefotaxime / Q000009:adverse effects / Q000627:therapeutic use*; D002511:Cephalosporins / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced; D010538:Peritonitis / Q000188:drug therapy* / Q000382:microbiology*; D016032:Randomized Controlled Trials as Topic; D012709:Serum Albumin / Q000009:adverse effects / Q000627:therapeutic use*
D002511:Cephalosporins; D012709:Serum Albumin; D002439:Cefotaxime